ROSE logo

Instituto Rosenbusch S.A. Stock Price

BASE:ROSE Community·AR$8.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ROSE Share Price Performance

AR$193.00
95.00 (96.94%)
AR$193.00
95.00 (96.94%)
Price AR$193.00

ROSE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Instituto Rosenbusch S.A. Key Details

AR$4.0b

Revenue

AR$4.9b

Cost of Revenue

-AR$887.2m

Gross Profit

AR$3.5b

Other Expenses

-AR$4.4b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-102.16
-21.95%
-107.62%
408.6%
View Full Analysis

About ROSE

Founded
1917
Employees
n/a
CEO
Rodolfo Martín Balestrini
WebsiteView website
www.rosenbusch.com

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.

Recent ROSE News & Updates

Recent updates

No updates

Instituto Rosenbusch S.A. Competitors